A perspective published in PLOS Medicine provides the justification for scaling up TB preventive therapy in high-burden countries.
"To end TB once and for all in high-burden countries, we need to prevent cases of TB disease arising from the large reservoir of latently infected persons and thereby interrupt transmission."